Rethinking Alzheimer's disease event with a focus on Sweden | 26 September 2023 | Full Recording

Alzheimer’s disease, the most common form of dementia, is a pressing issue for our lifetime. Society needs to be responsive to ensure that people can live with more dignity and access services and resources despite their diagnosis.

On 26 September 2023, the European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association of the Pharmaceutical Industry (LIF), organised a digital event “Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden”, exploring the ways we can rethink the Alzheimer’s care pathway, particularly in the Swedish healthcare context.

More than 380 people from all over the world registered to attend the event, including many representatives from the NGO sector, government institutions and industry.

The virtual event follows the launch of the Rethinking Alzheimer’s Disease White Paper: Detection & Diagnosis, looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment – MCI – stage) and what new care pathways would need to be implemented to reach out to patients at that stage.

Rethinking Alzheimer's disease virtual event:
0:00 - Introduction & Welcome Address: Joakim Ramsberg (Swedish Brain Foundation), Suzanne Dickson (European Brain Council)

5:45 - Keynote speech: Living with Alzheimer’s disease in a daily life: Maria Cavalli (NADIO - Need, Ask, Develop, Implement and Organize)

18:29 - Panel discussion and Q&A: From detection and diagnosis to innovative treatment and care: Frédéric Destrebecq (European Brain Council), Linus Jönsson (Karolinska Institutet), Prof. Kaj Blennow (University of Gothenburg), Joakim Ramsberg (Swedish Brain Foundation)

58:57 - Keynote address: Rethinking the Alzheimer’s care pathway in Sweden: Moa Wibom (Ängelholm Hospital)

1:09:24 - Panel discussion and Q&A: Healthcare system transformation: scaling up health systems’ readiness: JLaura Campo (Eli Lilly and Company), Giovanni Frisoni (Geneva University Hospital), Lina Nordquist (Swedish Liberal party), Gerd Lärfars (Swedish Association of Local Authorities and Regions), Joakim Ramsberg (Swedish Brain Foundation)

1:51:04 - Concluding remarks: What next?: Frédéric Destrebecq (European Brain Council), Joakim Ramsberg (Swedish Brain Foundation)